PP,FitzgeraldJD,etal.2012AmericanCollegeofRheumatologyguidelinesformanagementofgout・Part2:therapyandantiinflammatoryprophylaxisofacutegoutyarthritis[J]・ArthritisCareRes(Hoboken),2012,64:1447-1461.BeckerMA,MacDonaidPA,HuntBJ,eta1.Diabetesandgout:efficacyandsafetyoffebuxostatandallopurinol[J].DiabetesObesMetab,2013,15(11):1049-1055.[W]陈泽娜,古洁若.别瞟醇超敏反应研究进展.新医学,2016,47(3):142-145.[11]YunJ,MattssonJ,SchnyderK,FontanaS,LargiaderCR,PichlerWJ,YerlyD・Allopurinolhypersensitivityisprimarilymediatedbydose-dependentxypurinol-specificTcellresponse・ClinExpAllergy,2013,43(11):1246-1255.[12]Iwao0.Arepeatedoraladministrationstudyoffebuxostat(TMX-67),anon-purine-selectiveinhibitorofxanthineoxidase,inpatientswithimpairedrenalfunctioninJapan:icandpharmacodynamicstudy[J].JClinRheumatol,2011,17(4Suppl・2):S27-S34.
全文预览
